Skip to main content
KANGSTEM BIOTECH CO., LTD. logo

KANGSTEM BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 217730 ISIN · KR7217730001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2023-03-23 Declaration of Voting R…
Country KR South Korea
Listing KO 217730

About KANGSTEM BIOTECH CO., LTD.

https://kangstem.com

KANGSTEM BIOTECH CO., LTD. is a biopharmaceutical company that researches and develops advanced stem cell therapies. The company focuses on creating treatments for rare, incurable, and autoimmune diseases, with a pipeline that includes therapeutic candidates for neurological disorders. Leveraging proprietary technologies for the isolation and mass culture of mesenchymal stem cells, Kangstem Biotech also develops and commercializes stem cell culture media and related cosmetic products. The company is dedicated to addressing unmet medical needs through the development of next-generation biopharmaceuticals.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Regular General Meeting of Shareholders Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and director appointments. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), which reports the official outcomes of shareholder votes at a general meeting.
2023-03-23 Korean
[기재정정]사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for Kangstem Biotech, covering the fiscal period from January 1, 2022, to December 31, 2022. It contains detailed company information, history, capital structure, and management details, which are standard components of an Annual Report (10-K equivalent in the Korean regulatory context). The document is clearly a comprehensive annual filing rather than a short announcement or a specific supplement. FY 2022
2023-03-22 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides a summary of the audit opinion, financial statements (consolidated and separate), and key financial metrics like capital impairment and operating losses for the fiscal year. While it contains financial data, it is a summary announcement of the audit results rather than the full annual report (10-K) or a standalone audit report (AR). In the context of Korean regulatory filings (DART/KIND), this is a standard disclosure announcement regarding the receipt and submission of the audit report. FY 2022
2023-03-15 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the fiscal year 2022 (2022.01.01 ~ 2022.12.31) for Kangstem Biotech. In the South Korean regulatory context, the '사업보고서' is the equivalent of the US 10-K, serving as the comprehensive annual report containing financial statements, business overview, and governance details. It is not an announcement of a report, but the report itself. FY 2022
2023-03-15 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Kangstem Biotech. It outlines the date, location, and agenda items (financial statements, director appointments, and compensation limits). This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of upcoming voting matters, which falls under the Proxy Solicitation & Information Statement category.
2023-03-06 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Kangstem Biotech. It contains the meeting agenda, details on board activities, remuneration, and business overview (management discussion). This type of document is a standard proxy statement/notice for an AGM, which falls under the 'Proxy Solicitation & Information Statement' category in the provided schema.
2023-03-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.